Literature DB >> 25986060

Laparoscopic assisted versus open gastric pull-up following thoracoscopic esophagectomy: A cohort study.

Hiroyuki Daiko1, Takeo Fujita2.   

Abstract

BACKGROUND: Thoracolaparoscopic esophagectomy (TLE) is a type of minimally invasive esophagectomy (MIE) for esophageal cancer which consists of thoracoscopic resection and laparoscopic reconstruction. The aim of the present study was to evaluate the technical and oncological feasibility of alimentary tract reconstruction with laparoscopically assisted gastric pull-up (LAG) following thoracoscopic esophagectomy in the prone position (TSEP) in comparison with reconstruction with open laparotomy gastric pull-up (OLG) following TSEP, to establish TLE with extended lymph node dissection as a standard operation for esophageal cancer.
METHODS: Sixty-four patients with esophageal cancer underwent TSEP with 3-field lymphadenectomy from 2008 through 2010: for reconstruction after TSEP, 31 patients underwent LAG, and 33 patients underwent OLG. We retrospectively evaluated the technical and oncological feasibility of TLE with 3-field lymphadenectomy and compared surgical outcomes after reconstruction with OLG and that with LAG.
RESULTS: TLE with 3-field lymphadenectomy was successfully completed in 30 of 31 (97%) patients, and no surgery-related postoperative deaths occurred. No significant difference was found between LAG and OLG in the mean number of dissected abdominal lymph nodes, amount of blood loss, incidence of postoperative complications, mean postoperative hospital stay, restoration rate of respiratory function, or rate of complete resection or locoregional control, but the mean duration of abdominal procedures was significantly longer with LAG than with OLG.
CONCLUSION: This study demonstrates that the quality and safety of surgery and the oncological effectiveness of LAG for esophageal cancer. TLE consisting of LAG following TSEP with extended lymph-node dissection is a feasible surgical technique for thoracic esophageal carcinoma.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Laparoscopic surgery; Thoracoscopic surgery

Mesh:

Year:  2015        PMID: 25986060     DOI: 10.1016/j.ijsu.2015.04.040

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Clinical Effect and Postoperative Pain of Laparo-Thoracoscopic Esophagectomy in Patients with Esophageal Cancer.

Authors:  Yue Yu; Yun Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-26       Impact factor: 2.650

Review 2.  Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis.

Authors:  Waresijiang Yibulayin; Sikandaer Abulizi; Hongbo Lv; Wei Sun
Journal:  World J Surg Oncol       Date:  2016-12-08       Impact factor: 2.754

3.  Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter study.

Authors:  Isao Nozaki; Junki Mizusawa; Ken Kato; Hiroyasu Igaki; Yoshinori Ito; Hiroyuki Daiko; Masahiko Yano; Harushi Udagawa; Satoru Nakagawa; Masakazu Takagi; Yuko Kitagawa
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

4.  Totally minimally invasive esophagectomy versus hybrid minimally invasive esophagectomy: systematic review and meta-analysis.

Authors:  Frans van Workum; Bastiaan R Klarenbeek; Nikolaj Baranov; Maroeska M Rovers; Camiel Rosman
Journal:  Dis Esophagus       Date:  2020-08-03       Impact factor: 3.429

Review 5.  Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta-analysis.

Authors:  K Siaw-Acheampong; S K Kamarajah; R Gujjuri; J R Bundred; P Singh; E A Griffiths
Journal:  BJS Open       Date:  2020-09-07

6.  Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?

Authors:  Cary Jo R Schlick; Rhami Khorfan; David D Odell; Ryan P Merkow; David J Bentrem
Journal:  Ann Surg Oncol       Date:  2020-06-09       Impact factor: 4.339

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.